Constantine Davides
Stock Analyst at JMP Securities
(1.16)
# 3,759
Out of 5,043 analysts
109
Total ratings
33%
Success rate
-15.4%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Maintains: Market Outperform | $20 → $23 | $21.68 | +6.09% | 10 | Oct 10, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $38.97 | +23.17% | 1 | Sep 18, 2025 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $33 → $22 | $21.17 | +3.92% | 11 | Aug 12, 2025 | |
| OPCH Option Care Health | Maintains: Market Outperform | $36 → $38 | $27.91 | +36.15% | 6 | Jul 31, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $121.63 | +23.32% | 4 | Jul 16, 2025 | |
| EVH Evolent Health | Reiterates: Market Outperform | $13 | $7.81 | +66.45% | 10 | Jun 20, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $17.83 | - | 2 | Jun 18, 2025 | |
| HQY HealthEquity | Maintains: Market Outperform | $110 → $117 | $96.50 | +21.24% | 5 | Jun 4, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $12.66 | - | 3 | May 6, 2025 | |
| PRVA Privia Health Group | Reiterates: Market Outperform | $29 | $25.99 | +11.58% | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.97 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $93.16 | +21.30% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $18.17 | +43.09% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $191.52 | +29.49% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $26.31 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $12.96 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.49 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.53 | +243.14% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.92 | +13,486.96% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $24.27 | -38.20% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $17.71 | +27.05% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.25 | +161.54% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.37 | +921.90% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $3.92 | +9,083.67% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $2.24 | +144,542.86% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.72 | +5,468.70% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.44 | +1,251.35% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.88 | +42,453.19% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9,960 → $4,980 | $2.68 | +185,720.90% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.84 | +10,056.53% | 2 | Sep 23, 2022 |
OptimizeRx
Oct 10, 2025
Maintains: Market Outperform
Price Target: $20 → $23
Current: $21.68
Upside: +6.09%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $38.97
Upside: +23.17%
AMN Healthcare Services
Aug 12, 2025
Maintains: Market Outperform
Price Target: $33 → $22
Current: $21.17
Upside: +3.92%
Option Care Health
Jul 31, 2025
Maintains: Market Outperform
Price Target: $36 → $38
Current: $27.91
Upside: +36.15%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $121.63
Upside: +23.32%
Evolent Health
Jun 20, 2025
Reiterates: Market Outperform
Price Target: $13
Current: $7.81
Upside: +66.45%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $17.83
Upside: -
HealthEquity
Jun 4, 2025
Maintains: Market Outperform
Price Target: $110 → $117
Current: $96.50
Upside: +21.24%
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $12.66
Upside: -
Privia Health Group
Apr 28, 2025
Reiterates: Market Outperform
Price Target: $29
Current: $25.99
Upside: +11.58%
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.97
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $93.16
Upside: +21.30%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $18.17
Upside: +43.09%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $191.52
Upside: +29.49%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $26.31
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $12.96
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $19.49
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.53
Upside: +243.14%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.92
Upside: +13,486.96%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $24.27
Upside: -38.20%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $17.71
Upside: +27.05%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.25
Upside: +161.54%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.37
Upside: +921.90%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $3.92
Upside: +9,083.67%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $2.24
Upside: +144,542.86%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.72
Upside: +5,468.70%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.44
Upside: +1,251.35%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.88
Upside: +42,453.19%
Sep 28, 2022
Maintains: Buy
Price Target: $9,960 → $4,980
Current: $2.68
Upside: +185,720.90%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.84
Upside: +10,056.53%